Rise In Investment In The Bioinformatics Is Leading To Expansion Of The Computational Biology Market

Computational Biology Market


 Computational biology is one of the most rapidly advancing areas in all of biology. It combines principles from genomics, cellular biology, computer science, information science, and medicine and it contributes to advances in many areas of biology. Computational Biology includes the study and research of complex biological systems, the design and manipulation of complex systems, the analysis and measurement of complex biological functions, and the applications to these systems of various scientific disciplines. Computational Biology is the fastest growing area of scientific research and has a significant impact on advances in all areas of biology and medical research. Computational Biology employs techniques from physics, computer science, mathematics, and software engineering to study living things and systems at various scales from the single-cell up to human organs and muscles.

North America is estimated to exhibit significant growth in the global computational biology market and this is accredited to the rise in the funding on research organization especially in the United States. For example, The U.S. National Science Foundation accounts for about 25% of federal support to academic institutions for research in the fields of science and engineering. It provides grants and cooperative agreements to more than 2,000 colleges, universities, K-12 school systems, businesses, informal science organizations, and other research organizations in the United States.

Key factors driving the growth of the computational biology market are the rise in demand for predictive models, increasing application in human genome projects, and growing R &D for drug discovery. A growing number of clinical studies in pharmacogenomics and pharmacokinetics and growth in bioinformatics research has also augmented the growth of the computational biology market. The rise in research funding in bioinformatics is leading to more advancement in the field of computational biology. For instance, The National Institutes of Health is the largest public funder of biomedical research in the world, with 24 institutes and centers awarding $32 billion a year in grants to improve human life and reduce illness and disability.

Key Developments:

1.      In May 2020, Evogene Ltd. a computational biology company targeting to revolutionize life-science product development across several market segments, announces it's rebranding

2.      In March 2021, ALSA Ventures announced the launch of Promatix Inc., a Delaware incorporated company, to develop novel therapeutics with the potential to transform the treatment of cancer. Promatix will use its multi-omic proprietary database, TxPro, to mine for a novel, and validate existing, drug targets.

Comments

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)